Pleß, Ole 1976-
Ole Pless researcher
VIAF ID: 3678660 (Personal)
Permalink: http://viaf.org/viaf/3678660
Preferred Forms
- 100 0 _ ‡a Ole Pless ‡c researcher
- 100 1 _ ‡a Pleß, Ole ‡d 1976-
- 100 1 _ ‡a Pleß, Ole ‡d 1976-
4xx's: Alternate Name Forms (3)
5xx's: Related Names (1)
Works
Title | Sources |
---|---|
An automated and high-throughput-screening compatible pluripotent stem cell-based test platform for developmental and reproductive toxicity assessment of small molecule compounds | |
Automated real-time monitoring of human pluripotent stem cell aggregation in stirred tank reactors | |
The blood-brain barrier is dysregulated in COVID-19 and serves as a CNS entry route for SARS-CoV-2 | |
Crosstalk between phosphorylation and multi-site arginine/lysine methylation in C/EBPs. | |
A differential proteome screening system for post-translational modification-dependent transcription factor interactions. | |
Driving next-generation autophagy researchers towards translation (DRIVE), an international PhD training program on autophagy | |
Effects of exercise on Irisin, BDNF and IL-6 serum levels in patients with progressive multiple sclerosis. | |
Functional role of the interaction between polysialic acid and myristoylated alanine-rich C kinase substrate at the plasma membrane | |
G9a-mediated lysine methylation alters the function of CCAAT/enhancer-binding protein-beta. | |
Human iPSC‐Derived Blood‐Brain Barrier Models: Valuable Tools for Preclinical Drug Discovery and Development? | |
A hybrid approach unveils drug repurposing candidates targeting an Alzheimer pathophysiology mechanism | |
Identifikation und Charakterisierung von Protein-Interaktionspartnern des Transkriptionsfaktors CCAAT, Enhancer-Binding-Protein [beta] | |
Interfacing human induced pluripotent stem cell-derived neurons with designed nanowire arrays as a future platform for medical applications | |
Lipid Mediator Profiles Predict Response to Therapy with an Oral Frankincense Extract in Relapsing-Remitting Multiple Sclerosis | |
Molecular Characterization of the NLRC4 Expression in Relation to Interleukin-18 Levels | |
A multiple sclerosis-associated variant of CBLB links genetic risk with type I IFN function. | |
Rapid establishment of the European Bank for induced Pluripotent Stem Cells (EBiSC) - the Hot Start experience | |
A screening strategy for the discovery of drugs that reduce C/EBPβ-LIP translation with potential calorie restriction mimetic properties | |
Short-term molecular and physiological responses to heat stress in neritic copepods Acartia tonsa and Eurytemora affinis | |
Targets of the Tal1 transcription factor in erythrocytes: E2 ubiquitin conjugase regulation by Tal1 |